NCT06123832View on ClinicalTrials.gov

Study of the Clinical Benefits of Different Formulations of Amphotericin B

Active, not recruitingOBSERVATIONAL
Enrollment

184

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

August 31, 2024

Study Completion Date

December 31, 2024

Conditions
EfficacySafety
Trial Locations (1)

Unknown

Rui Yang,MD, Jinan

All Listed Sponsors
lead

Qianfoshan Hospital

OTHER

NCT06123832 - Study of the Clinical Benefits of Different Formulations of Amphotericin B | Biotech Hunter | Biotech Hunter